Vencanna VenturesVENCF +80.00% Gross Margin % is -8.13% as of Jan. 2026. The stock has 4 warning signs investors should review. Among 938 Drug Manufacturers companies, Vencanna Ventures ranks worse than 98.83% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vencanna Ventures had a gross margin of -8.13% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vencanna Ventures Gross Margin % Related Terms
Vencanna Ventures Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vencanna Ventures's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vencanna Ventures Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vencanna Ventures's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vencanna Ventures (VENCF) has a Gross Margin % of -8.13% as of Jan. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Vencanna Ventures and its competitors. According to the industry distribution chart, Vencanna Ventures ranks #927 out of 938 companies in the Drug Manufacturers industry, placing it in the top 98.8%.
Is Vencanna Ventures' Gross Margin % too high?
Vencanna Ventures' current Gross Margin % is -8.13%. Based on the distribution chart, Vencanna Ventures ranks #927 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vencanna Ventures' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #927 out of 938 companies for Gross Margin %. This places Vencanna Ventures in the lower half of its industry. The industry median Gross Margin % is 48.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current Gross Margin % is -8.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current Gross Margin % of -8.13%. The current Gross Margin % is -8.13%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current Gross Margin % is -8.13% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VENCF has been successfully added to your 